# Top 50 Biotech Startup Investors in Denmark in June 2026

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 30
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## BioInnovation Institute
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 19
- Stages: Convertible Note, Pre-Seed, Debt Financing
- Focus: Biotechnology, Medical, Health Care

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

## Vaekstfonden
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 16
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

## Export and Investment Fund
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 15
- Stages: Seed, Series A
- Focus: Software, Biotechnology, Health Care

Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.

## Seed Capital
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 9
- Stages: Seed, Series A
- Focus: Software, Health Care, SaaS

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

## PSV
- Type: VC Fund
- Location: Lyngby, Hovedstaden, Denmark
- Relevant deals: 8
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.

## Nordic Foodtech VC
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 6
- Stages: Seed, Series A
- Focus: Biotechnology, Life Science, Water

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

## Oskare Capital
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 6
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, Biotechnology, Medical

Oskare Capital is a venture capital firm.

## Sunstone Life Science Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 6
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

## Gilde Healthcare
- Type: VC Fund
- Location: Utrecht, Utrecht, The Netherlands
- Relevant deals: 5
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Medical

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

## West Hill Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 4
- Stages: Series A, Seed
- Focus: Software, Health Care, Financial Services

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

## The Footprint Firm
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 4
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Renewable Energy, Energy Management

The Footprint Firm is an advisory and investment company with a sole focus on sustainability. 

## Per Falholt
- Type: Angel
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 4
- Stages: Pre-Seed, Series A, Seed
- Focus: Biotechnology, Robotics, Biopharma

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

## ACME Capital
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Software, Health Care, Mobile

ACME Capital is a venture capital and private equity firm that invests in breakthrough technologies that fuel platform shifts and disruptive business models that capitalize on new platforms. Its purpose is to support those founders who choose to take their capital.
The firm was founded in 2018 and headquartered in San Francisco, California.

## Ysios Capital
- Type: VC Fund
- Location: San Sebastian, Pais Vasco, Spain
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

## DSM Venturing
- Type: VC Fund
- Location: Heerlen, Limburg, The Netherlands
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Manufacturing

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable. 

## VF Venture
- Type: VC Fund
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, SaaS, Biotechnology

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

## RA Capital Management
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 4
- Stages: Series B, Series C, Post-IPO Equity
- Focus: Biotechnology, Health Care, Therapeutics

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

## PINC
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Seed, Pre-Seed, Series A
- Focus: Biotechnology, Food and Beverage, Coffee

PINC was launched as Paulig Incubator in 2018 to help Paulig stay in the forefront of relevant innovations, as well as to contribute to a tastier, healthier and more sustainable planet. Today, our ambition is the same, but we have developed into a corporate venture arm. We aim for strategic, financial, and societal impact in our investments,fostering a sustainable food system for tomorrow. We are investing across the agrifood value chain in three primary impact themes:   Improve planetary health and diet within the current food system: This includes innovations in agriculture and food security, such as advanced crop breeding or green fertilizers, innovative ingredients and next generation healthy foods, as well as solutions for tracking and improving climate and nature. Novel technologies to feed 10 BN people by 2050: Technologies needed to sustainably produce enough food for our growing population. This includes food production without land use change, such as precision fermentation and cell-culture.  A circular system for food & materials: Regardless of whether we grow our food in soil or in bioreactors, the system needs to be circular. Some examples are upcycled ingredients, food from unused sources, new coating and packaging solutions, as well as technologies to prevent or make better use of side streams. We are looking for entrepreneurs in an attractive market space with an intrinsic drive to find a solution to the problem they are addressing, a clear and scalable plan for success, a reliable team and partners whom we can trust and work closely with.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

## Atlantic
- Type: VC Fund
- Location: Berlin, Berlin, Germany
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Health Care, Financial Services

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

## Ugly Duckling Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Pre-Seed, Seed
- Focus: Software, Information Technology, Artificial Intelligence

At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale. 

## Bioqube Ventures
- Type: VC Fund
- Location: Hasselt, Limburg, Belgium
- Relevant deals: 3
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Therapeutics, Life Science

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.

## Nicholas Francis
- Type: Angel
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: SaaS, Robotics, Software

Nicholas Francis is Co-founder at framebunker

## Innovation Fund Denmark
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Grant, Pre-Seed, Seed
- Focus: Software, Biotechnology, SaaS

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

## EIR Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Therapeutics

EIR Ventures is a new Life Science Venture Group in the Nordics.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Unconventional Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Software, Wellness

Unconventional Ventures invests in startups in the pre-seed and seed stage led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.

## Blue Horizon Corporation
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 3
- Stages: Seed, Series A, Pre-Seed
- Focus: Food and Beverage, Food Processing, Biotechnology

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

## NOON Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Biotechnology, AgTech, Farming

Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.

## Thia Ventures
- Type: VC Fund
- Location: Genève, Geneve, Switzerland
- Relevant deals: 3
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Food and Beverage

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

## SR One
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

## Steen Riisgaard
- Type: Angel
- Relevant deals: 2
- Stages: Pre-Seed
- Focus: Life Science, Therapeutics, Biotechnology

Steen Riisgaard

## Wellington Partners
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

## Lundbeckfonden Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

## Giampaolo Cagnin
- Type: Angel
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Food and Beverage, Plant-Based Foods

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

## Bruce Linton
- Type: Angel
- Location: Ottawa, Ontario, Canada
- Relevant deals: 2
- Stages: Post-IPO Equity, Seed, Pre-Seed
- Focus: Cannabis, Health Care, Biotechnology

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

## SOSV
- Type: VC Fund
- Location: Princeton, New Jersey, United States
- Relevant deals: 2
- Stages: Seed, Convertible Note, Pre-Seed
- Focus: Biotechnology, Health Care, Software

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

## CAPNOVA
- Type: VC Fund
- Location: Aarhus, Midtjylland, Denmark
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, B2B

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

## Verve Ventures
- Type: VC Fund
- Location: Zug, Zug, Switzerland
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Health Care, Software, Biotechnology

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

## Aescap Venture
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Pharmaceutical, Chemical

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

## Industrifonden
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Information Technology

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

## The Yield Lab Europe
- Type: VC Fund
- Location: Dublin, Dublin, Ireland
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: AgTech, Agriculture, Biotechnology

The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry.  The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.

## +ND Capital
- Type: VC Fund
- Location: San Mateo, California, United States
- Relevant deals: 2
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Medical

+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.

## Northzone
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, E-Commerce

Northzone is a multi-stage venture capital fund that seeks to invest in the healthcare, semiconductors, software, hardware, artificial intelligence, blockchain, and gaming industries.

## Dawn Biopharma
- Type: VC Fund
- Location: Wilmington, Delaware, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Dawn Biopharma is a global investment firm of KKR.

## Novo Ventures
- Type: VC Fund
- Location: Bagsværd, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## Balderton Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Software, FinTech, Financial Services

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

## Newtree Impact
- Type: VC Fund
- Location: Belgium, Wisconsin, United States
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology

We invest in disruptive and encouraging Agri-Food tech and Food Loss companies, reshaping our food systems in order to solve the current & future problems of production.

## HTGF (High-Tech Gruenderfonds)
- Type: VC Fund
- Location: Bonn, Nordrhein-Westfalen, Germany
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Biotechnology, Information Technology

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.